• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

七氟醚和富勒醇 C60 对链脲佐菌素诱导的糖尿病小鼠下肢缺血再灌注损伤心肺的影响。

Effects of Sevoflurane and Fullerenol C60 on the Heart and Lung in Lower-Extremity Ischemia-Reperfusion Injury in Streptozotocin-Induced Diabetes Mice.

机构信息

Department of Anesthesiology and Reanimation, Faculty of Medicine, Gazi University, Ankara 06560, Turkey.

Department of Histology and Embryology, Faculty of Medicine, Gazi University, Ankara 06560, Turkey.

出版信息

Medicina (Kaunas). 2024 Jul 29;60(8):1232. doi: 10.3390/medicina60081232.

DOI:10.3390/medicina60081232
PMID:39202513
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11356023/
Abstract

: Lower-extremity ischemia-reperfusion injury can induce distant organ ischemia, and patients with diabetes are particularly susceptible to ischemia-reperfusion injury. Sevoflurane, a widely used halogenated inhalation anesthetic, and fullerenol C60, a potent antioxidant, were investigated for their effects on heart and lung tissues in lower-extremity ischemia-reperfusion injury in streptozotocin (STZ)-induced diabetic mice. : A total of 41 mice were divided into six groups: control ( = 6), diabetes-control ( = 7), diabetes-ischemia ( = 7), diabetes-ischemia-fullerenol C60 ( = 7), diabetes-ischemia-sevoflurane ( = 7), and diabetes-ischemia-fullerenol C60-sevoflurane ( = 7). Diabetes was induced in mice using a single intraperitoneal dose of 55 mg/kg STZ in all groups except for the control group. Mice in the control and diabetes-control groups underwent midline laparotomy and were sacrificed after 120 min. The DIR group underwent 120 min of lower-extremity ischemia followed by 120 min of reperfusion. In the DIR-F group, mice received 100 μg/kg fullerenol C60 intraperitoneally 30 min before IR. In the DIR-S group, sevoflurane and oxygen were administered during the IR procedure. In the DIR-FS group, fullerenol C60 and sevoflurane were administered. Biochemical and histological evaluations were performed on collected heart and lung tissues. : Histological examination of heart tissues showed significantly higher necrosis, polymorphonuclear leukocyte infiltration, edema, and total damage scores in the DIR group compared to controls. These effects were attenuated in fullerenol-treated groups. Lung tissue examination revealed more alveolar wall edema, hemorrhage, vascular congestion, polymorphonuclear leukocyte infiltration, and higher total damage scores in the DIR group compared to controls, with reduced injury parameters in the fullerenol-treated groups. Biochemical analyses indicated significantly higher total oxidative stress, oxidative stress index, and paraoxonase-1 levels in the DIR group compared to the control and diabetic groups. These levels were lower in the fullerenol-treated groups. : Distant organ damage in the lung and heart tissues due to lower-extremity ischemia-reperfusion injury can be significantly reduced by fullerenol C60.

摘要

: 下肢缺血再灌注损伤可引起远隔器官缺血,糖尿病患者尤其容易发生缺血再灌注损伤。七氟醚是一种广泛应用的卤代吸入麻醉剂,富勒醇 C60 是一种有效的抗氧化剂,本研究旨在探讨七氟醚和富勒醇 C60 对链脲佐菌素(STZ)诱导的糖尿病小鼠下肢缺血再灌注损伤后心肺组织的影响。 : 共 41 只小鼠分为六组:对照组(n = 6)、糖尿病对照组(n = 7)、糖尿病缺血组(n = 7)、糖尿病缺血富勒醇 C60 组(n = 7)、糖尿病缺血七氟醚组(n = 7)和糖尿病缺血富勒醇 C60 七氟醚组(n = 7)。除对照组外,其余各组小鼠均通过单次腹腔注射 55mg/kg STZ 诱导糖尿病。对照组和糖尿病对照组小鼠行正中开腹术,120min 后处死。DIR 组行 120min 下肢缺血,再灌注 120min。在 DIR-F 组中,IR 前 30min 给予小鼠腹腔注射 100μg/kg 富勒醇 C60。在 DIR-S 组中,IR 过程中给予七氟醚和氧气。在 DIR-FS 组中,给予富勒醇 C60 和七氟醚。收集心、肺组织,行生化和组织学评估。 : 心脏组织的组织学检查显示,与对照组相比,DIR 组的心肌坏死、多形核白细胞浸润、水肿和总损伤评分显著升高,而富勒醇治疗组的这些作用减弱。肺组织检查显示,与对照组相比,DIR 组的肺泡壁水肿、出血、血管充血、多形核白细胞浸润和总损伤评分更高,而富勒醇治疗组的损伤参数减少。生化分析显示,与对照组和糖尿病对照组相比,DIR 组的总氧化应激、氧化应激指数和对氧磷酶 1 水平显著升高,而富勒醇治疗组的这些水平降低。 : 下肢缺血再灌注损伤引起的远隔器官肺和心脏组织损伤可被富勒醇 C60 显著减轻。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0528/11356023/76ebe329f12e/medicina-60-01232-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0528/11356023/d579b7d9ffd0/medicina-60-01232-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0528/11356023/7bc940a21f6f/medicina-60-01232-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0528/11356023/2c51fb368cd7/medicina-60-01232-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0528/11356023/594ce381fbc5/medicina-60-01232-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0528/11356023/9a61c9deb376/medicina-60-01232-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0528/11356023/99457255e3d9/medicina-60-01232-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0528/11356023/be6c3cc54214/medicina-60-01232-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0528/11356023/4aabff4a5fd4/medicina-60-01232-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0528/11356023/4aa50523e4b4/medicina-60-01232-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0528/11356023/9a4960176f45/medicina-60-01232-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0528/11356023/af787ee32a51/medicina-60-01232-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0528/11356023/76ebe329f12e/medicina-60-01232-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0528/11356023/d579b7d9ffd0/medicina-60-01232-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0528/11356023/7bc940a21f6f/medicina-60-01232-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0528/11356023/2c51fb368cd7/medicina-60-01232-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0528/11356023/594ce381fbc5/medicina-60-01232-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0528/11356023/9a61c9deb376/medicina-60-01232-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0528/11356023/99457255e3d9/medicina-60-01232-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0528/11356023/be6c3cc54214/medicina-60-01232-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0528/11356023/4aabff4a5fd4/medicina-60-01232-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0528/11356023/4aa50523e4b4/medicina-60-01232-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0528/11356023/9a4960176f45/medicina-60-01232-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0528/11356023/af787ee32a51/medicina-60-01232-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0528/11356023/76ebe329f12e/medicina-60-01232-g012.jpg

相似文献

1
Effects of Sevoflurane and Fullerenol C60 on the Heart and Lung in Lower-Extremity Ischemia-Reperfusion Injury in Streptozotocin-Induced Diabetes Mice.七氟醚和富勒醇 C60 对链脲佐菌素诱导的糖尿病小鼠下肢缺血再灌注损伤心肺的影响。
Medicina (Kaunas). 2024 Jul 29;60(8):1232. doi: 10.3390/medicina60081232.
2
Effects of sevoflurane and fullerenol C60 on lower limb ischemia-reperfusion injury in streptozocin-induced diabetic mice.七氟醚和富勒醇 C60 对链脲佐菌素诱导的糖尿病小鼠下肢缺血再灌注损伤的影响。
Sci Prog. 2024 Apr-Jun;107(2):368504241239444. doi: 10.1177/00368504241239444.
3
The Effect of Sevoflurane and Fullerenol C 60 on the Liver and Kidney in Lower Extremity Ischemia-Reperfusion Injury in Mice with Streptozocin-Induced Diabetes.七氟醚和富勒醇 C60 对链脲佐菌素诱导糖尿病小鼠下肢缺血再灌注损伤肝肾功能的影响。
Int J Nanomedicine. 2023 Dec 12;18:7543-7557. doi: 10.2147/IJN.S432924. eCollection 2023.
4
Effect of fullerenol C60 on lung and renal tissue in lower extremity ischemia‑reperfusion injury in sevoflurane‑treated rats.富勒醇 C60 对七氟醚处理大鼠下肢缺血再灌注损伤肺和肾组织的影响。
Mol Med Rep. 2024 Mar;29(3). doi: 10.3892/mmr.2024.13178. Epub 2024 Feb 9.
5
The Effect of Cerium Oxide (CeO) on Ischemia-Reperfusion Injury in Skeletal Muscle in Mice with Streptozocin-Induced Diabetes.氧化铈(CeO)对链脲佐菌素诱导糖尿病小鼠骨骼肌缺血再灌注损伤的影响。
Medicina (Kaunas). 2024 Apr 30;60(5):752. doi: 10.3390/medicina60050752.
6
Effects of fullerenol nanoparticles on kidney tissue in sevoflurane‑treated rats.富勒醇纳米颗粒对七氟醚处理大鼠肾脏组织的影响。
Bratisl Lek Listy. 2020;121(2):117-121. doi: 10.4149/BLL_2020_015.
7
Ozone Administration Reduces Myocardial Ischemia Reperfusion Injury in Streptozotocin Induced Diabetes Mellitus Rat Model.臭氧治疗可减轻链脲佐菌素诱导的糖尿病大鼠心肌缺血再灌注损伤。
Drug Des Devel Ther. 2024 Sep 20;18:4203-4213. doi: 10.2147/DDDT.S482309. eCollection 2024.
8
The effect of levosimendan on lung damage after myocardial ischemia reperfusion in rats in which experimental diabetes was induced.左西孟旦对诱导实验性糖尿病大鼠心肌缺血再灌注后肺损伤的影响。
J Surg Res. 2015 Feb;193(2):920-5. doi: 10.1016/j.jss.2014.08.038. Epub 2014 Aug 28.
9
The Effect of Cerium Oxide on Lung Tissue in Lower Extremity Ischemia Reperfusion Injury in Sevoflurane Administered Rats.铈氧化物对七氟醚麻醉大鼠下肢缺血再灌注损伤肺组织的影响。
Int J Nanomedicine. 2020 Oct 6;15:7481-7489. doi: 10.2147/IJN.S263001. eCollection 2020.
10
Isoflurane-sevoflurane adminstration before ischemia attenuates ischemia-reperfusion-induced injury in isolated rat lungs.在缺血前给予异氟烷-七氟烷可减轻离体大鼠肺脏缺血-再灌注诱导的损伤。
Anesthesiology. 2000 Mar;92(3):833-40. doi: 10.1097/00000542-200003000-00027.

引用本文的文献

1
Investigating the protective effects of fullerenol-C60 on kidney and lung tissues in streptozotocin-induced diabetic rats with cecal sepsis.研究富勒醇-C60对链脲佐菌素诱导的伴有盲肠败血症的糖尿病大鼠肾和肺组织的保护作用。
Sci Rep. 2025 May 30;15(1):19096. doi: 10.1038/s41598-025-04423-4.

本文引用的文献

1
Sevoflurane enhances autophagy via Rac1 to attenuate lung ischaemia‒reperfusion injury.七氟醚通过 Rac1 增强自噬来减轻肺缺血再灌注损伤。
Chem Biol Interact. 2024 Jul 1;397:111078. doi: 10.1016/j.cbi.2024.111078. Epub 2024 May 28.
2
The Effect of Cerium Oxide (CeO) on Ischemia-Reperfusion Injury in Skeletal Muscle in Mice with Streptozocin-Induced Diabetes.氧化铈(CeO)对链脲佐菌素诱导糖尿病小鼠骨骼肌缺血再灌注损伤的影响。
Medicina (Kaunas). 2024 Apr 30;60(5):752. doi: 10.3390/medicina60050752.
3
Protective effects of hydrogen rich saline solution in rats with experimental myocardial ischemia reperfusion injury.
富氢盐溶液对实验性心肌缺血再灌注损伤大鼠的保护作用。
Heliyon. 2023 Nov 28;9(12):e22973. doi: 10.1016/j.heliyon.2023.e22973. eCollection 2023 Dec.
4
Diabetic vascular diseases: molecular mechanisms and therapeutic strategies.糖尿病血管病变:分子机制与治疗策略。
Signal Transduct Target Ther. 2023 Apr 10;8(1):152. doi: 10.1038/s41392-023-01400-z.
5
Streptozotocin as a tool for induction of rat models of diabetes: a practical guide.链脲佐菌素作为诱导大鼠糖尿病模型的工具:实用指南。
EXCLI J. 2023 Feb 21;22:274-294. doi: 10.17179/excli2022-5720. eCollection 2023.
6
The burden and risks of emerging complications of diabetes mellitus.糖尿病新并发症的负担和风险。
Nat Rev Endocrinol. 2022 Sep;18(9):525-539. doi: 10.1038/s41574-022-00690-7. Epub 2022 Jun 6.
7
The Protective Effect of Sevoflurane Conditionings Against Myocardial Ischemia/Reperfusion Injury: A Systematic Review and Meta-Analysis of Preclinical Trials in Models.七氟烷预处理对心肌缺血/再灌注损伤的保护作用:对动物模型临床前试验的系统评价和荟萃分析
Front Cardiovasc Med. 2022 Apr 28;9:841654. doi: 10.3389/fcvm.2022.841654. eCollection 2022.
8
Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association.《心脏病与卒中统计-2022 更新:美国心脏协会报告》。
Circulation. 2022 Feb 22;145(8):e153-e639. doi: 10.1161/CIR.0000000000001052. Epub 2022 Jan 26.
9
Sevoflurane Alleviates Myocardial Ischemia Reperfusion Injury by Inhibiting P2X7-NLRP3 Mediated Pyroptosis.七氟醚通过抑制P2X7-NLRP3介导的细胞焦亡减轻心肌缺血再灌注损伤
Front Mol Biosci. 2021 Oct 26;8:768594. doi: 10.3389/fmolb.2021.768594. eCollection 2021.
10
Ischemia-Reperfusion Injury in Lung Transplantation.肺移植中的缺血再灌注损伤。
Cells. 2021 May 28;10(6):1333. doi: 10.3390/cells10061333.